VivoSeq
Other

Analgesia

1

Pipeline Programs

24

Active Trials

0

Companies Involved

Analgesia is an early-stage landscape with 1 program across 0 companies.

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

36/100

Mech. Concentration

100/100

Completion Rate

83/100

Attrition Rate

11/100

Programs by Phase

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

130

clinical trials

Completed71 · 55%
Unknown status20 · 15%
Recruiting10 · 8%
Not yet recruiting9 · 7%
Terminated7 · 5%
Withdrawn7 · 5%
Other6 · 5%

Trial Activity

130 trials

Prehospital Analgesia INtervention Trial (PAIN)
Recruiting··Phase 3·NCT05437575·994 enrolled
Evaluation of Analgesia for Cardiac Elective Surgery in Children
Recruiting··Phase 3·NCT06626035·500 enrolled
Morphine or Ketamine for Analgesia
Not yet recruiting··Phase 3·NCT06835504·1,010 enrolled
Page 1 of 9

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)